DK1420028T3 - Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf - Google Patents

Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Info

Publication number
DK1420028T3
DK1420028T3 DK03292864T DK03292864T DK1420028T3 DK 1420028 T3 DK1420028 T3 DK 1420028T3 DK 03292864 T DK03292864 T DK 03292864T DK 03292864 T DK03292864 T DK 03292864T DK 1420028 T3 DK1420028 T3 DK 1420028T3
Authority
DK
Denmark
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
DK03292864T
Other languages
Danish (da)
English (en)
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1420028T3 publication Critical patent/DK1420028T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03292864T 2003-11-19 2003-11-19 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf DK1420028T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292864A EP1420028B1 (fr) 2003-11-19 2003-11-19 Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
DK1420028T3 true DK1420028T3 (da) 2007-06-18

Family

ID=32116380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03292864T DK1420028T3 (da) 2003-11-19 2003-11-19 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Country Status (29)

Country Link
US (1) US7208607B1 (ja)
EP (1) EP1420028B1 (ja)
JP (1) JP4377412B2 (ja)
KR (1) KR100863394B1 (ja)
CN (1) CN100447152C (ja)
AR (1) AR047312A1 (ja)
AT (1) ATE354586T1 (ja)
AU (1) AU2004295132B2 (ja)
BR (1) BRPI0416746B1 (ja)
CA (1) CA2546506C (ja)
CY (1) CY1106544T1 (ja)
DE (1) DE60311942T2 (ja)
DK (1) DK1420028T3 (ja)
EA (1) EA010102B1 (ja)
EG (1) EG26629A (ja)
ES (1) ES2282586T3 (ja)
GE (1) GEP20084547B (ja)
HK (1) HK1096689A1 (ja)
MA (1) MA28144A1 (ja)
MX (1) MXPA06005607A (ja)
MY (1) MY138550A (ja)
NO (1) NO336349B1 (ja)
NZ (1) NZ546931A (ja)
PL (1) PL210769B1 (ja)
PT (1) PT1420028E (ja)
SI (1) SI1420028T1 (ja)
UA (1) UA83269C2 (ja)
WO (1) WO2005054276A1 (ja)
ZA (1) ZA200603675B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380591B1 (fr) * 2003-08-29 2005-11-16 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
JP2007517056A (ja) 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールｄａａｏ阻害剤
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
RU2430913C2 (ru) 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
JP5438975B2 (ja) 2006-01-06 2014-03-12 サノビオン ファーマシューティカルズ インク テトラロン系モノアミン再取り込み阻害剤
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN112047869B (zh) * 2020-08-20 2021-12-21 华南理工大学 一种氮杂5,6-并环化合物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Also Published As

Publication number Publication date
CN1882607A (zh) 2006-12-20
EG26629A (en) 2014-04-13
ES2282586T3 (es) 2007-10-16
PT1420028E (pt) 2007-05-31
HK1096689A1 (en) 2007-06-08
CN100447152C (zh) 2008-12-31
CY1106544T1 (el) 2012-01-25
AU2004295132A1 (en) 2005-06-16
KR20060121202A (ko) 2006-11-28
JP4377412B2 (ja) 2009-12-02
BRPI0416746A (pt) 2007-01-16
MA28144A1 (fr) 2006-09-01
AU2004295132B2 (en) 2010-07-15
DE60311942T2 (de) 2007-12-06
US7208607B1 (en) 2007-04-24
BRPI0416746B1 (pt) 2018-02-14
AR047312A1 (es) 2006-01-18
SI1420028T1 (sl) 2007-06-30
UA83269C2 (uk) 2008-06-25
CA2546506C (fr) 2010-04-06
WO2005054276A1 (fr) 2005-06-16
EA200600898A1 (ru) 2006-10-27
US20070083052A1 (en) 2007-04-12
ZA200603675B (en) 2007-09-26
NO336349B1 (no) 2015-08-03
JP2008502587A (ja) 2008-01-31
ATE354586T1 (de) 2007-03-15
PL380409A1 (pl) 2007-01-22
EA010102B1 (ru) 2008-06-30
CA2546506A1 (fr) 2005-06-16
MXPA06005607A (es) 2006-08-17
EP1420028A2 (fr) 2004-05-19
PL210769B1 (pl) 2012-02-29
EP1420028A3 (fr) 2004-05-26
EP1420028B1 (fr) 2007-02-21
GEP20084547B (en) 2008-11-25
DE60311942D1 (de) 2007-04-05
NO20062599L (no) 2006-06-06
NZ546931A (en) 2010-01-29
KR100863394B1 (ko) 2008-10-14
MY138550A (en) 2009-06-30

Similar Documents

Publication Publication Date Title
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1753720T3 (da) Fremgangsmåde til fremstilling af perindopril og salte deraf
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
NO20050885D0 (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1422236T3 (da) Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf